Christopher Paul German serves as Executive at RHYTHM PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Christopher Paul German has executed 9 insider transactions totaling $466.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2025 involved selling 1,500 shares valued at $142.5K.
Christopher Paul German currently holds 922 shares of RHYTHM PHARMACEUTICALS, INC. (RYTM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Paul German has been a net seller of RYTM stock. They have purchased $0 and sold $466.1K worth of shares.
Christopher Paul German's most recent insider trade was on Aug 12, 2025, when they sold 1,500 shares at $95.00 per share.
Get notified when new Form 4 filings are submitted
| $49.23 |
| Discretionary |
| Aug 12, 2025 | RYTM | $18.0K | Option Exercise | 1,000 | $17.97 | Discretionary |
| Jul 9, 2025 | RYTM | $151.0K | Sale | 1,967 | $76.75 | Discretionary |
| Jul 9, 2025 | RYTM | $41.8K | Option Exercise | 850 | $49.23 | Discretionary |
| Jul 9, 2025 | RYTM | $35.9K | Option Exercise | 2,000 | $17.97 | Discretionary |
| Jul 9, 2025 | RYTM | $157.3K | Sale | 1,850 | $85.00 | Discretionary |
| Apr 2, 2024 | RYTM | $15.4K | Sale | 368 | $41.76 | Discretionary |
| Mar 20, 2024 | RYTM | $0 | Option Exercise | 1,163 | $N/A | Discretionary |